122807-12-9

Basic information

• Product Name: Carbamic acid, [2-(bromoacetyl)phenyl]-, ethyl ester
• CAS NO: 122807-12-9
• Molecular Formula: C11H12BrNO3
• Molecular Weight: 286.125
• Mol File: 122807-12-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [2-(bromoacetyl)phenyl]-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [2-(bromoacetyl)phenyl]-, ethyl ester(122807-12-9)
• EPA Substance Registry System: Carbamic acid, [2-(bromoacetyl)phenyl]-, ethyl ester(122807-12-9)

Safety Data

• Hazardous Substances Data: 122807-12-9(Hazardous Substances Data)

Upstream product

• 551-93-9 2-aminoacetophenone 
• 6140-13-2 (2-acetylphenyl)carbamic acid ethyl ester 

Downstream Products

• 15000-43-8 2,4-dihydroxyquinoline-3-carbonitrile 
• 72119-96-1 (Z)-2-aminocinnamonitrile 
• 123197-72-8 N-<2-(2-cyano-1-hydroxyethyl)phenyl>ethyl carbamate 
• 123197-70-6 2-ethoxycarbonylaminostyrene oxide 
• 13307-67-0 ethyl 1H-indole-1-carboxylate 
• 58106-57-3 (E)-3-(2-aminobenzene)acrylonitrile 
• 580-22-3 2-aminoquinoline 
• 123197-68-2 N-<2-(2-bromo-1-hydroxyethyl)phenyl>ethyl carbamate 
• 138768-58-8 1,4-bis(2-ethoxycarbonylaminophenyl)-2-cyano-1,4-butanedione 
• 138768-57-7 ethyl N-<2-(2-cyanoacetyl)phenyl>carbamate 

Relevant articles and documents

Searching new structural scaffolds for BRAF inhibitors. An integrative study using theoretical and experimental techniques

The identification of the V600E activating mutation in the protein kinase BRAF in around 50% of melanoma patients has driven the development of highly potent small inhibitors (BRAFi) of the mutated protein. To date, Dabrafenib and Vemurafenib, two specifi